BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 133 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2018. The put-call ratio across all filers is 0.63 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $18,000 | -86.2% | 116 | -87.0% | 0.00% | -100.0% |
Q2 2022 | $130,000 | -99.7% | 892 | -99.8% | 0.00% | -99.8% |
Q1 2022 | $48,170,000 | -8.1% | 406,256 | +6.8% | 0.43% | -2.1% |
Q4 2021 | $52,428,000 | +385.4% | 380,437 | +389.3% | 0.44% | +356.2% |
Q3 2021 | $10,801,000 | +7.6% | 77,758 | -24.8% | 0.10% | +10.3% |
Q2 2021 | $10,035,000 | +38.9% | 103,364 | -2.2% | 0.09% | +29.9% |
Q1 2021 | $7,225,000 | -16.6% | 105,712 | +4.5% | 0.07% | -26.4% |
Q4 2020 | $8,666,000 | +11.7% | 101,112 | -15.3% | 0.09% | -10.8% |
Q3 2020 | $7,758,000 | +10.5% | 119,340 | +24.3% | 0.10% | +3.0% |
Q2 2020 | $7,022,000 | +56.3% | 96,041 | -27.3% | 0.10% | +25.3% |
Q1 2020 | $4,493,000 | -41.1% | 132,037 | -5.7% | 0.08% | -22.5% |
Q4 2019 | $7,624,000 | +24.8% | 140,046 | -4.3% | 0.10% | +18.6% |
Q3 2019 | $6,107,000 | +34.8% | 146,376 | +41.5% | 0.09% | +24.6% |
Q2 2019 | $4,531,000 | -15.9% | 103,480 | -1.1% | 0.07% | -20.7% |
Q1 2019 | $5,388,000 | +20.1% | 104,679 | -13.7% | 0.09% | -2.2% |
Q4 2018 | $4,486,000 | – | 121,306 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 896,844 | $123,594,000 | 67.92% |
RP Management, LLC | 1,111,111 | $153,122,000 | 64.09% |
ORACLE INVESTMENT MANAGEMENT INC | 2,075,402 | $286,011,000 | 40.64% |
ARS Investment Partners, LLC | 463,392 | $63,860,000 | 5.86% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 300,373 | $41,394,000 | 4.76% |
SILVERARC CAPITAL MANAGEMENT, LLC | 80,348 | $11,073,000 | 4.49% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,900 | $19,282,000 | 4.30% |
Avidity Partners Management LP | 1,140,000 | $157,103,000 | 3.33% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $27,562,000 | 3.17% |
Eventide Asset Management | 1,635,000 | $225,319,000 | 2.88% |